Targeting of Metabotropic Glutamate Receptors for the Development of Novel Antidepressants
Since discovering that ketamine has robust antidepressant effects, the glutamatergic system has been proposed as an attractive target for the development of novel antidepressants. Among the glutamatergic system, metabotropic glutamate (mGlu) receptors are of interest because mGlu receptors play modu...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-04-01
|
| Series: | Chronic Stress |
| Online Access: | https://doi.org/10.1177/2470547019837712 |